Earnings call: BeautyHealth faces headwinds, focuses on turnaround
During The Beauty Health Company’s (ticker: SKIN) second quarter 2024 earnings call, CEO Marla Beck...
During The Beauty Health Company’s (ticker: SKIN) second quarter 2024 earnings call, CEO Marla Beck...
Comstock Mining Inc. (NYSE: NYSE:) has made substantial progress across its business segments, including strategic...
By Nidal al-Mughrabi CAIRO (Reuters) -An Israeli airstrike on a Gaza City school compound housing...
STAAR Surgical Company (STAA) has reported record net sales of $99 million for the second...
Saputo Inc. (SAP.TO), a leading global dairy processor, has reported strong financial results for the...
Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) reported a challenging second quarter in 2024, with total...
Wojcicki, one of the most influential female executives in Silicon Valley, had been living with lung cancer for two years.
Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data submitted to date,” and requested an additional late-stage study.
The lawsuit is the latest in a series of legal actions taken against Musk by former leaders at Twitter since he took over.